KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cvs Health (CVS) Accumulated Depreciation & Amortization (2016 - 2025)

Cvs Health's Accumulated Depreciation & Amortization history spans 17 years, with the latest figure at $24.7 billion for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 5.53% year-over-year to $24.7 billion, compared with a TTM value of $24.7 billion through Dec 2025, up 5.53%, and an annual FY2025 reading of $24.7 billion, up 5.53% over the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $24.7 billion at Cvs Health, up from $23.4 billion in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $24.7 billion in Q4 2025, with the low at $4.2 billion in Q4 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $15.5 billion, with a median of $20.7 billion recorded in 2023.
  • Year-over-year, Accumulated Depreciation & Amortization decreased 5.87% in 2022 and then surged 387.38% in 2023.
  • Tracing CVS's Accumulated Depreciation & Amortization over 5 years: stood at $4.5 billion in 2021, then dropped by 5.87% to $4.2 billion in 2022, then skyrocketed by 387.38% to $20.7 billion in 2023, then grew by 13.28% to $23.4 billion in 2024, then rose by 5.53% to $24.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Accumulated Depreciation & Amortization are $24.7 billion (Q4 2025), $23.4 billion (Q4 2024), and $20.7 billion (Q4 2023).